SCHEMBL5587771

SCHEMBL5587771

CCCCCCCCc1cccc2c1Oc1c(CCCCCCCC)c(O)c(O)c(CCCCCCCC)c1O2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.44
PTGS2 P35354 1/20 0.44
TYR P14679 2/20 0.43
BID P55957 3/20 0.43
MCL1 Q07820 3/20 0.43
BCL2L1 Q07817 2/20 0.43
BAK1 Q16611 2/20 0.43
KAT8 Q9H7Z6 2/20 0.43
CYP1A1 P04798 1/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
EP300 Q09472 1/20 0.43
KAT2A Q92830 1/20 0.43
KAT2B Q92831 1/20 0.43
KAT5 Q92993 1/20 0.43
SAE1 Q9UBE0 1/20 0.43
LIPG Q9Y5X9 1/20 0.42
KIF20B Q96Q89 1/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587849 1.00 ALOX5 (0.44) ALOX5PTGS2TYRBIDMCL1
SCHEMBL5587734 1.00 ALOX5 (0.44) ALOX5PTGS2TYRBIDMCL1
SCHEMBL5587846 1.00 ALOX5 (0.44) ALOX5PTGS2TYRBIDMCL1
SCHEMBL5590559 0.99 ALOX5 (0.46) ALOX5PTGS2TYRBIDMCL1
SCHEMBL5587995 0.94 CYP1A1 (0.40) ALOX5PTGS2TYRBIDMCL1
SCHEMBL7054345 0.87 LIPG (0.49) ALOX5PTGS2BIDMCL1BCL2L1
SCHEMBL18153979 0.87 LIPG (0.49) ALOX5PTGS2BIDMCL1BCL2L1
SCHEMBL29432879 0.87 LIPG (0.49) ALOX5PTGS2BIDMCL1BCL2L1
SCHEMBL5588626 0.85 GABRA1 (0.36) ALOX5PTGS2CYP1A1
SCHEMBL5587035 0.85 CYP1A1 (0.54) ALOX5PTGS2TYRCYP1A1LIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALOX5 188/4885PTGS2 3242/4885TYR 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.